Finding Patterns In Clinical Trial Experiences of Patients With Eczema
NCT05747378 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 500
Last updated 2023-05-30
Summary
Historically, participation in clinical trials has been skewed towards certain groups. However, research on the factors that influence participation, both positive and negative, is limited.
Eczema clinical trial patients help us identify these factors by sharing trial experiences during the course of the observational medical study.
This study will include a diverse group of participants to gather a wide range of information on clinical trial experiences. The collected data will then be used to benefit future eczema patients who are considering participating in a clinical study.
Conditions
Sponsors & Collaborators
-
Power Life Sciences Inc.
lead INDUSTRY
Principal Investigators
-
Michael B Gill · Power Life Sciences Inc.
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-03-31
- Primary Completion
- 2025-03-31
- Completion
- 2026-03-31
More Related Trials
-
A Clinical Trial to Evaluate the Safety and Efficacy of a Moisturizer Body Lotion in Adults of Atopic Dermatitis.
NCT05062213 ·Status: COMPLETED ·Phase: NA
-
Skin Efficacy and Tolerability of a Cosmetic Product Combination Over 3 Months in Subjects With Atopic Eczema
NCT05790083 ·Status: UNKNOWN ·Phase: NA
-
To Evaluate the Safety and Efficacy of a New Device in the Management of Mild to Moderate Atopic Dermatitis in Children
NCT00886587 ·Status: COMPLETED ·Phase: NA
-
Eczeva Supplementation and Skin Health
NCT07049770 ·Status: COMPLETED ·Phase: NA
-
Evaluate Efficacy, PK, and Safety of FB825 in Adults With Atopic Dermatitis
NCT04413942 ·Status: UNKNOWN ·Phase: PHASE2
-
A Study of an Eczema Spot Treatment in Providing Eczema Symptoms Relief and Lasting Itch Relief to Affected Skin Area
NCT05226143 ·Status: COMPLETED ·Phase: NA
-
Determine the Dose-dependent Efficacy and Safety of EC-18 in Patients With Moderate to Severe Atopic Dermatitis
NCT06487000 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
A Study to Learn About Study Medicine Called PF-08049820 in People With Eczema
NCT07216027 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Pilot Study to Test the Effects of Arctiva on Mild to Moderate Eczema
NCT05918237 ·Status: COMPLETED ·Phase: NA
-
Assessment of Clinical, Biological and Biometrological Paramaters in Adult Subjects Suffering From AD
NCT05639738 ·Status: TERMINATED ·Phase: NA
-
Safety and Efficacy Study of EVO101 Topical Cream in Atopic Dermatitis
NCT05579899 ·Status: COMPLETED ·Phase: PHASE2
-
Tolerance Evaluation of a Nighttime Moisturizing Balm on Babies and Adults With Eczema
NCT02357940 ·Status: COMPLETED ·Phase: NA
-
Study of CM512 in Healthy Subjects and Patients With Atopic Dermatitis
NCT06553209 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of LY3471851 in Participants With Eczema
NCT04081350 ·Status: COMPLETED ·Phase: PHASE1
-
DEC033 Study Product for Mild to Moderate Eczema An Open-label, Adaptive-design Pilot Study
NCT02379507 ·Status: COMPLETED ·Phase: PHASE1
-
Skin Microbial Ecology in Atopic Dermatitis
NCT04170244 ·Status: RECRUITING
-
A Study of LY3454738 in Healthy Participants and Participants With Atopic Dermatitis
NCT03750643 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy Evaluation and Cutaneous Acceptibility of a Dermocosmetic Product on Subjects Suffering of Atopic Dermatisis.
NCT06756438 ·Status: RECRUITING ·Phase: NA
-
A Study of the Medicine Called Abrocitinib in Children 6 to Less Than 12 Years of Age With Moderate-to-Severe Eczema
NCT06807268 ·Status: RECRUITING ·Phase: PHASE3
-
Efficacy and Safety Study of Apremilast in Subjects With Moderate to Severe Atopic Dermatitis
NCT02087943 ·Status: COMPLETED ·Phase: PHASE2
-
Study in Healthy Participants and Participants With Moderate Atopic Dermatitis & Optionally, Moderate Psoriasis, and/or Mild Asthma
NCT04927195 ·Status: COMPLETED ·Phase: PHASE1
-
Real-World Study on the Impact of Atopic Dermatitis From a Caregiver Perspective
NCT07323394 ·Status: NOT_YET_RECRUITING
-
Efalizumab for Eczema
NCT00146003 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase III Extended Clinical Trial of Jaktinib Hydrochloride Tablets in the Treatment of Moderate and Severe Atopic Dermatitis
NCT05676242 ·Status: RECRUITING ·Phase: PHASE3
-
Cosmetic Study to Improve the Appearance of Skin Afflicted With Mild to Moderate Atopic Dermatitis.
NCT03268174 ·Status: COMPLETED ·Phase: NA